These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1208549)

  • 21. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation studies in women on combination type of oral contraceptives.
    Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR
    J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the oral contraceptive preparation Femigen on the erythrocyte and resin uptake of 131-I-triiodothyronine].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1972 May; 43(5):595-600. PubMed ID: 4113023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABH blood group antigens during pregnancy and in women on hormonal contraceptives.
    Dalal RM; Sathe MS; Bhatia HM
    Indian J Med Res; 1982 Aug; 76():201-6. PubMed ID: 7174011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sister chromatid exchanges in the lymphocytes of control women, pregnant women, and women taking oral contraceptives: effects of cell culture temperature.
    Ghosh R; Ghosh PK
    Environ Mol Mutagen; 1988; 12(2):179-83. PubMed ID: 3409874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
    Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
    Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vitamin B6 requirement in oral contraceptive users. I. Assessment by pyridoxal level and transferase activity in erythrocytes.
    Bossé TR; Donald EA
    Am J Clin Nutr; 1979 May; 32(5):1015-23. PubMed ID: 433818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.
    Melis GB; Fruzzetti F; Paoletti AM; Carmassi F; Fioretti P
    Contraception; 1984 Dec; 30(6):575-83. PubMed ID: 6241562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation and anticoagulation effects of contraceptive steroids.
    Samsioe G
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1523-7. PubMed ID: 8178901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.